deCODE biostructures Initiates Research Collaboration with Cubist Pharmaceuticals
News Feb 13, 2008
deCODE biostructures, Inc. announces the signing of a collaborative research agreement with Cubist Pharmaceuticals. Under the terms of the agreement, deCODE biostructures will conduct gene to structure research on multiple proprietary targets.
Specifically, deCODE will be providing Cubist with access to deCODE’s expertise in conducting high-throughput crystallography experiments in parallel with the goal of solving multiple high resolution protein-ligand structures. deCODE will also facilitate the interpretation of X-ray structure models for structure-guided drug design efforts.
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
10th International Tissue Repair and Regeneration Congress
Jun 13 - Jun 14, 2019
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019